Article Details

Replimune, Roche to Develop RP3 in Colorectal Cancer, Hepatocellular Carcinoma >REPL

Retrieved on: 2022-12-07 12:14:46

Tags for this article:

Click the tags to see associated articles and topics

Replimune, Roche to Develop RP3 in Colorectal Cancer, Hepatocellular Carcinoma >REPL. View article details on hiswai:

Excerpt

By Colin Kellaher Replimune Group Inc. on Tuesday said it inked a deal to work with Swiss pharmaceutical company Roche Holding AG to advance ...

Article found on: www.marketwatch.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up